PHIO

#4756
Phio Pharmaceuticals Corp. Common Stock
1.2900 USD
+4.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
1.2900
1.2900
Rango anual
0.9780
1.3500
Cambio diario
+4.03%
Variación mensual
+6.61%
Variación en los últimos 6 meses
+8.40%
Cambio anual
+8.40%
Cierres anteriores
1.2400
Abrir
1.2900
Bid
Ask
Mínimo
1.2900
High
1.2900
Volumen
3
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor 202020212022202320242025 TTM

Phio Pharmaceuticals Corp

Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018.

Noticias